Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-12-01T01:58:16.081Z Has data issue: false hasContentIssue false
  • English
  • Français

Bloodstream Infection: An Ounce of Prevention Is a Ton of Work

Published online by Cambridge University Press:  21 June 2016

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 6 , June 2005 , pp. 511 - 514
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

References

1.Arnow, PM, Quimosing, EM, Beach, M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778–784.Google Scholar
2.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598–1601.CrossRefGoogle ScholarPubMed
3.Collignon, PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994;161:374–378.CrossRefGoogle Scholar
4.Relio, J, Ochagavia, A, Sabanes, E, et al.Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027–1030.Google Scholar
5.Smith, RL, Meixler, SM, Simberkoff, MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164–167.CrossRefGoogle ScholarPubMed
6.Percival, SL, Kite, P, Eastwood, K, et al.Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005;26:515–519.Google Scholar
7.Bleyer, AJ, Mason, L, Russell, G, Raad, II, Sherertz, RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005;26:520–524.Google Scholar
8.Rubinson, L, Wu, AW, Haponik, EF, Diette, GB. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol 2005;26:525–533.CrossRefGoogle Scholar
9.Engemann, JJ, Friedman, JY, Reed, SD, et al.Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control and Hospital Epidemiol 2005;26:534–539.Google Scholar
10.Morgan, J, Meitzer, MI, Plikaytis, BD, et al.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005;26:540–547.CrossRefGoogle ScholarPubMed
11.Maki, DG, Mermel, LA. Infections due to infusion therapy. In: Bennet, JV, Brachman, PS, eds. Hospital Infections. Philadelphia: Lippincott Raven; 1998:689–724.Google Scholar
12.Safdar, N, Maki, DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004;30:62–67.CrossRefGoogle ScholarPubMed
13.Crnich, CJ, Maki, DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: II. Long-term devices. Clin Infect Dis 2002;34:1362–1368.CrossRefGoogle ScholarPubMed
14.Sitges-Serra, A, Puig, P, Linares, J, et al.Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr 1984;8:668–672.Google Scholar
15.Raad, I, Costerton, W, Sabharwal, U, Sacilowski, M, Anaissie, E, Bodey, GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400–407.Google Scholar
16.Garland, JS, Alex, CP, Mueller, CD, et al.A randomized trial comparing povidone-iodine to a Chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431–1436.Google Scholar
17.Bouza, E, Burillo, A, Munoz, P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother 2001;13:224–233.Google Scholar
18.Carratala, J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001;7(suppl 4):83–90.Google Scholar
19.Capdevila, JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998;2:230–236.CrossRefGoogle ScholarPubMed
20.Safdar, N, Maki, D. The use of vancomycin lock and flush solutions for the prevention of catheter-related bloodstream infection. Presented at the 15th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.Google Scholar
21.Jurewitsch, B, Lee, T, Park, J, Jeejeebhoy, K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998;22:242–244.CrossRefGoogle ScholarPubMed
22.Dogra, GK, Herson, H, Hutchison, B, et al.Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13:2133–2139.Google Scholar
23.Chatzinikolaou, I, Zipf, TF, Hanna, H, et al.Minocycline-ethylenedi-aminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003;36:116–119.Google Scholar
24.Maki, DG, Crnich, CJ, Safdar, N. Ethanol lock solution for prevention of recurrent DTDR BSI. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Chicago, IL.Google Scholar
25.Kite, P, Eastwood, K, Sugden, S, Percival, SL. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004;42:3073–3076.CrossRefGoogle ScholarPubMed
26.Chaiyakunapruk, N, Veenstra, DL, Lipsky, BA, Saint, S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002;136:792–801.Google Scholar
27.Raad, II, Hohn, DC, Gilbreath, BJ, et al.Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.CrossRefGoogle ScholarPubMed
28.Berenholtz, SM, Pronovost, PJ. Barriers to translating evidence into practice. Curr Opin Crit Care 2003;9:321–325.Google Scholar
29.Maue, SK, Segal, R, Kimberlin, CL, Lipowski, EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. American Journal of Managed Care 2004;10:383–391.Google Scholar
30.Cabana, MD, Rand, CS, Powe, NR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458–1465.CrossRefGoogle ScholarPubMed
31.Pathman, DE, Konrad, TR, Freed, GL, Freeman, VA, Koch, GG. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care 1996;34:873–889.Google Scholar
32.Davis, DA, Thomson, MA, Oxman, AD, Haynes, RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700–705.CrossRefGoogle ScholarPubMed
33.O'Grady, NP, Alexander, M, Dellinger, EP, et al.Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51(RR-10):1–29.Google ScholarPubMed
34.Berenholtz, SM, Pronovost, PJ, Lipsett, PA, et al.Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.Google Scholar
35.Rosenthal, VD, Guzman, S, Pezzetto, SM, Crnich, CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31:405–409.Google Scholar
36.Dopirak, M, Hill, C, Oleksiw, M, et al.Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 2002;23:721–724.CrossRefGoogle ScholarPubMed
37.Sexton, DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001;15:731–742, vii.CrossRefGoogle ScholarPubMed
38.Tokars, JI. Bloodstream infections in hemodialysis patients: getting some deserved attention. Infect Control Hosp Epidemiol 2002;23:713–715.Google Scholar
39.Reed, SD, Friedman, JY, Engemann, JJ, et al.Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:175–183.Google Scholar
40.Tokars, JI, Frank, M, Alter, MJ, Arduino, MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15:162–171.Google Scholar
41.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887–892.CrossRefGoogle ScholarPubMed